Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cervical Adenocarcinoma”

1,209 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,209 results

Early research (Phase 1)Ended earlyNCT00290719
What this trial is testing

Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
University of California, San Francisco 6
Early research (Phase 1)Study completedNCT03000257
What this trial is testing

Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
AbbVie 182
Testing effectiveness (Phase 2)Study completedNCT00918281
What this trial is testing

Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection

Who this might be right for
Solid TumorsHigh Grade GliomasLung Cancer+4 more
GE Healthcare 70
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT03037385
What this trial is testing

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more
Hoffmann-La Roche 590
Early research (Phase 1)Study completedNCT04641871
What this trial is testing

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 78
Not applicableUnknownNCT03411187
What this trial is testing

Study on the Application of Convenient Foot-control Exhaust Method in Endoscopic Thyroidectomy

Who this might be right for
Thyroid CancerPapillary Thyroid CarcinomaThyroidectomy+1 more
Bo Wang,MD 100
Testing effectiveness (Phase 2)WithdrawnNCT03592407
What this trial is testing

Epacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal Cancer

Who this might be right for
Esophageal Squamous Cell CarcinomaEsophageal AdenocarcinomaGastroesophageal Junction Adenocarcinoma
City of Hope Medical Center
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Large-scale testing (Phase 3)Study completedNCT00295763
What this trial is testing

A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.

Who this might be right for
Differentiated Thyroid Cancer
Genzyme, a Sanofi Company 61
Testing effectiveness (Phase 2)Study completedNCT00066716
What this trial is testing

Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Weill Medical College of Cornell University 39
Early research (Phase 1)Study completedNCT00537121
What this trial is testing

Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer

Who this might be right for
Esophageal CancerGastric CancerLiver Cancer
Roswell Park Cancer Institute 23
Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Testing effectiveness (Phase 2)Looking for participantsNCT04984733
What this trial is testing

Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer

Who this might be right for
Adenocarcinoma - GEJCancer of Esophagus
University of Southampton 18
Not applicableNot Yet RecruitingNCT06725628
What this trial is testing

Multiomics Study of Biological Behavior of Lymph Node Metastasis in Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid CarcinomaLymph Node Cancer Metastatic
Tianhan Zhou 2,000
Testing effectiveness (Phase 2)Study completedNCT01229930
What this trial is testing

Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by Surgery

Who this might be right for
Cervical Cancer
University of Glasgow 130
Early research (Phase 1)Looking for participantsNCT07348211
What this trial is testing

First in Human Study of SIM0610 in Solid Tumors

Who this might be right for
Advanced Solid TumoursNon-Small Cell Lung CancerColorectal Cancer+2 more
Jiangsu Simcere Pharmaceutical Co., Ltd. 260
Testing effectiveness (Phase 2)Active Not RecruitingNCT04280081
What this trial is testing

Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation

Who this might be right for
Solid TumorMedullary Thyroid Cancer
Eli Lilly and Company 77
Testing effectiveness (Phase 2)Study completedNCT00016900
What this trial is testing

PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06953089
What this trial is testing

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Who this might be right for
Solid Tumors
DualityBio Inc. 492
Load More Results